Close Menu
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
Facebook X (Twitter) Instagram
Facebook LinkedIn
Financial Market News
Subscribe Now
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
Financial Market News
You are at:Home»Posts Tagged "LILLY DRN" (Page 2)

Trump health care plan likely good for pharmaceutical companies

By FinMar NewsJanuary 26, 2025

U.S. President Donald Trump speaks about prescription drug prices during an appearance in the Brady Press Briefing Room at the White House in Washington, U.S., November…

GLP-1s, Brian Thomson killing loom large at JPM Health

By FinMar NewsJanuary 19, 2025

Jamie Dimon, chief executive officer of JPMorgan Chase & Co., at the Institute of International Finance (IIF) during the annual meetings of the IMF and World…

Medicare drug price negotiations list includes Ozempic

By FinMar NewsJanuary 18, 2025

A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating Type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo,…

Medicare can cover Eli Lilly’s Zepbound for sleep apnea: Health Department

By FinMar NewsJanuary 10, 2025

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Brendan McDermid | ReutersMedicare drug plans can…

Investing Club’s Q3 2024 Earnings Report Card

By FinMar NewsJanuary 4, 2025

Another earning season is over. The winners? Most of our stocks. Twenty-three out of 33 portfolio names delivered third-quarter reports were deemed good or great by…

FDA Zepbound shortage ends, impacts patients, compounding pharmacies

By FinMar NewsDecember 29, 2024

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Brendan McDermid | ReutersThe roughly $1,000 monthly…

FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea

By FinMar NewsDecember 21, 2024

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024. Shelby Knowles | Bloomberg |…

Novo Nordisk shares plunge 20% after disappointing trial results; Lilly

By FinMar NewsDecember 20, 2024

Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy.Hollie Adams | ReutersShares of Danish pharmaceutical giant Novo Nordisk plummeted more than…

Here’s what can go right to lift each of our 34 portfolio stocks

By FinMar NewsDecember 1, 2024

Sometimes, there can be an overwhelming amount of negativity and noise on Wall Street. To counter that, Jim Cramer has said investors should not lose sight…

Jim Cramer’s top 10 things to watch in the stock market Tuesday

By FinMar NewsNovember 26, 2024

My top 10 things to watch Tuesday, Nov. 26 1. The outgoing Biden administration proposed a rule that would expand access to obesity drugs for millions…

Previous 1 2 3 Next
Energy News

Kuwait says Hormuz closure will trigger domino effect across the world

Texas leads nation in solar power installation, report finds – Houston

The economy has Strait of Hormuz deadline for Trump: Two weeks

Amid energy market turmoil, the people taking power into their own hands

Banks News

The Shadow of Stablecoin Regulation Looms, Crypto-Related Stocks Suffer

Glia Wins AI Excellence Award in Banking and Financial Services Category

Down 12% This Year, Nubank Plans a ‘100b Pivot’ And Investors Are Taking

JPMorgan Chase Stock Faces Headwinds Ahead of Earnings

Real Estate News

SMBC Arm, Aravest Get $165 Million for APAC Real Estate Credit

Manhattan Real Estate Report: Is this the ”It’s Always SOMETHING” moment

License EDU Launches Real Estate Continuing Education Courses in Texas

UNL Releases Preliminary Farm Real Estate Market Survey Results for

© 2026 finmar.news

Type above and press Enter to search. Press Esc to cancel.